GTP is a precursor of RNA, DNA, and a number of other fundamental metabolites. Among these are riboflavin and the deazaflavin derivatives related to F 420 , the pterin related coenzymes tetrahydrobiopterin (BH 4 ), tetrahydrofolate (THF), methanopterin, and molybdopterin, and a variety of 7-deazaguanine derivatives such as queuosine (Q) and archaeosine (G + ), found in tRNA, and toyacamycin and tubercidin which are secondary metabolites produced in Streptomyces.
Many of the enzymes involved in the synthesis of these GTP derived metabolites are members of the same structural superfamily, the Tunnel-fold or T-fold superfamily (1) . This superfamily is comprised of a functionally diverse set of enzymes that assemble through oligomerization of a core domain comprised of a pair of two-stranded anti-parallel -sheets and two helices to form a 2n n barrel (1) . Two barrels associate in a head-to-head fashion, and bind planar substrates such as purines or pterins at the interface using a conserved Glu/ Gln residue to anchor the substrate. Illustrating the diversity of the reactions catalyzed by Tfold enzymes, two enzymes of the BH 4 synthesis pathway ( Figure 1A ) belong to the T-fold superfamily GTP cyclohydrolase IA (GCYH-IA or FolE) and 6-pyruvoyl-tetrahydropterin synthase (PTPS-II or PtpS) (2); GCYH-IA catalyzes the first step of the pathway producing 7,8-dihydroneopterin triphosphate (H 2 NTP) from GTP (3, 4) . H 2 NTP is then converted to 6-pyruvoyl-tetrahydropterin (PTP) by PTPS-II (5, 6)} ( Figure 1A ). PTP is then reduced to BH 4 by sepiapterin reductase (SR encoded by the spr gene and part of the dehydrogenasereductase (SDR) superfamily) (7-9).
GCYH-IA is also the first enzyme of the THF biosynthetic pathway (3) . It is replaced in some organisms by GTP cyclohydrolase IB (GCYH-IB or FolE2) (10), another T-fold enzyme (11). In most plants and Bacteria the THF pathway contains a second T-fold enzyme, dihydroneopterin aldolase (DHNA) encoded in Escherichia coli by folB (12) ( Figure 1A ). furthermore, in Plasmodium falciparum and various bacteria, the DHNA step is bypassed by yet another T-fold enzyme, PTPS-III, a homolog of PTPS-II, that cleaves the side chain of H 2 NTP to form 6-hydroxylmethyl-7,8-dihydropterin (6HMDP) (13-15) ( Figure 1A ).
Queuosine (Q) is a 7-deazaguanosine derivative found at position 34 of several bacterial and eukaryal tRNAs (16-18), while archaeosine (G + ), a related derivative, is found specifically at position 15 of archaeal tRNA (19) . Like the flavin and folate pathways, the Q/G + pathways are populated by T-fold enzymes and GCYH-IA (or GCYH-IB) catalyzes the first biosynthetic steps (20) . The second enzyme of the pathway, PTPS-I or QueD, is homologous to PTPS-II and catalyzes the formation of 6-carboxy-5,6,7,8-tetrahydropterin from DHNTP in vitro (21) ( Figure 1A) . Finally, the enzyme QueF, an oxidoreductase that reduces the nitrile side chain of 7-cyano-7-deazaguanine (preQ 0 ) the last common intermediate in the Q and G + pathways (22, 23) , to the aminomethyl side chain of 7-aminomethyl-7-deazaguanine (preQ 1 ), is also a T-fold enzyme (24).
Functional diversity is found not only between the different T-fold sub-families but also within a given subfamily. As alluded to above, three members of the COG0720 subfamily, PTPS-I, II, and III have been shown to catalyze different reactions in different pathways ( Figure 1A) , and a fourth COG0720 member, PTPS-IV, whose structure was recently determined, has an as yet unknown function (25).
By combining comparative genomic with biochemical and genetic characterization, we provide evidence that the COG0720 family is an example of a family of enzyme containing functionally promiscuous members. This functional promiscuity is exploited in vivo with single enzymes contributing different reactions to different pathways.
RESULTS

Separation of Four COG0720 Subfamilies by Comparative Genomics
Because of its functional diversity, the COG0720 family of enzymes is particularly difficult to annotate. Out of 810 bacterial COG0720 sequences in the NCBI database as of July 2010, 516 are annotated in RefSeq (26) as 6-pyruvoyltetrahydropterin synthase, or PTPS-II. However, with the exception of specific cyanobacteria that synthesize glycosylated BH 4 derivatives (27), the BH 4 pathway is absent in most of these organisms, and thus these enzymes likely have activities other than that of a PTPS-II. To illustrate the difficulty of annotating COG0720 members using sequence similarity (BLAST score) alone, the rat PTPS-II protein (NP_058916.1) was used as input to search the Synechococcus sp. PCC7942 genome using default BLASTP parameters (28), and two COG0720 proteins were retrieved. The one with the lowest similarity (YP_400201.1; E-value: 5e-20) has robust canonical PTPS-II activity in vitro, whereas the one with the highest similarity (YP_400970.1; E-value 6e-31) exhibits only low activity, and deletion of the corresponding gene does not affect BH 4 levels in vivo (27) . Transferring the function of the experimentally characterized member of the family, the rat PTPS-II, to the best scoring homolog in Synechococcus sp. PCC7942 therefore results in an erroneous annotation. In order to better annotate the COG0720 family other types of association evidence were required. Using the SEED database (29), we performed a comparative genomic analysis of the four PTPS families (I to IV). A subsystem named "Experimental-PTPS" was constructed that included all the COG0720 homologs in the database. More than one copy of the gene was found in 114 of the 918 genomes analyzed, confirming that the misannotation risk is indeed very high.
Physical clustering analysis revealed that specific members of the COG0720 subfamilies could be efficiently separated by analyzing their genomic context. Twenty four COG0720 genes cluster with other genes of the BH 4 pathway such as folE and spr ( Figure 1B and see "Experimental PTPS" subsystem in SEED) and hence were annotated as ptpS genes encoding PTPS-II enzymes. Another 283 COG0720 genes cluster with queuosine genes (queCEF) (30) and folE or folE2 (20) ( Figure 1B and See "Experimental PTPS" subsystem in SEED) and were therefore annotated as queD encoding PTPS-I enzymes. Finally, 16 COG0720 genes cluster with folate biosynthesis genes such as folE, folK, and folP ( Figure  1B and see "Experimental PTPS" subsystem in SEED) and were annotated as encoding PTPS-III enzymes.
We derived signature motifs for these three subfamilies of enzymes using the PRATT tool from PROSITE suite (31) as well as Web Logo 3.0 (32). The sequences of the experimentally characterized enzymes, as well as sequences from additional members predicted through physical clustering, were used as input for each COG0720 subgroup. Previous sequence and structural analysis of the PTPS-III family had shown that it could be distinguished from the PTPS-II family by the presence of specific motifs surrounding the catalytic residues (13); {CX(5)-H-G-H} for PTPS-II enzymes, and {E-X(2)-H-G-H} for PTPS-III enzymes. We confirmed and slightly expanded these two signature motifs and identified the signature motif for the PTPS-I family as {C-X(3)-H-G-H} (Supplemental Figure 1 ).
PTPS-IV encoding genes are found only in a few halophilic Archaea and Actinomycetes (a total of 14 organisms), and members of the PTPS-IV family are still of unknown function, although physical clustering suggests a link with riboflavin. Indeed, in Archaea PTPS-IV genes cluster with GTP-cyclohydrolase III (GCYH-III) genes (arfA) (33) and in Bacteria with GTP-cyclohydrolase II genes (ribA2) that contain mutations conferring GTPcyclohydrolase III type activity (34), and in both they further cluster with a formamide hydrolase gene (arfB) that encodes the subsequent enzyme in this GCYH-III dependent riboflavin pathway (35). We therefore predict that PTPS-IV proteins are involved in the synthesis of a product derived from 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5 -phosphate (APy), the riboflavin/F 420 biosynthetic intermediate generated by the ArfA and ArfB proteins. A PTPS-IV signature motif, {F-X(0,1)-G-X-[ANTV]-[NPQST]} was identified using the 14 PTPS-IV sequences as input ( Figure 1 and Figure S1 ). Finally, two groups of COG0720 proteins (PTPS-V and VI) that do not contain any of the motifs identified in the PTPS-I/II/III/IV families were found in Crenarchaea (listed in Supplemental data 1). The PTPS-V members are found in all sequenced Pyrobaculum sp., in Vulcanisaeta sp. and in Thermoproteus neutrophilus and contain a {S-X(2)-W-X(3)-H-G-H} motif. The PTPS-VI members are found in Metallosphaera sedula DSM 5348 and in all sequenced Sulfolobus species and contain a {S-S-X(4)-Q-X-H-G-H} motif. The functions of these last two families of COG0720 proteins are unknown.
The combination of physical clustering and motif analysis allowed us to differentiate six COG0720 subfamilies and derive signature motifs that were used to propagate the annotations in the SEED database (see "Experimental-PTPS" subsystem).
PTPS-I/III Enzymes Can Function in Both Folate and Q Pathways
Genomic analysis revealed that a group of bacteria (Supplemental Table 1 ) contained only one COG0720 encoding gene but were predicted to require both PTPS-III and PTPS-I activities as they possessed Q biosynthetic genes (queCEF) as well as the signature folate genes folK and folP (examples are shown in Figure 2A ), but lacked folB (encoding DHNA). Closer analysis of the COG0720 proteins encoded in these organisms revealed that they contained a hybrid PTPS-I/PTPS-III motif {C-E-X-[ILPV]-H-G-H} (Supplemental Table 1 ). We had previously shown that the predicted PTPS-I/III Sa enzyme from Syntrophus acidotrophicus (YP_462286.1) exhibited PTPS-III activity in vivo as the corresponding gene complemented the thymidine (dT) auxotrophy of an E.coli folB strain (15). However, physical clustering linked the corresponding gene to the Q biosynthesis pathway ( Figure  1B ). More generally, out of 38 genes encoding proteins containing the dual motif, 7 of them cluster with folate biosynthesis genes and 14 of them cluster with Q biosynthesis genes (See "Experimental PTPS" subsystem in SEED). To test whether the PTPS-III proteins containing hybrid motifs also exhibited PTPS-I activity, we examined the nucleoside constituents of bulk tRNA purified from cultures of WT E. coli transformed with pBAD24 (Table 1) . Expressing a canonical PTPS-III Li gene from Leptospira interrogans (NP_712930.1) did not lead to complementation of the Q − phenotype (Table 1) , whereas the same clone was effective in complementing the dT auxotrophy phenotype of the folB strain (15). In addition, the PTPS-I Cb (YP_0011383898.1) and PTPS-I/III Cb (YP_001383205.1) genes from Clostridium botulinum strain 19397 were analyzed in both complementation tests. In this organism, the PTPS-I Cb gene clusters with Q biosynthesis genes and the PTPS-I/III Cb gene clusters with folate biosynthesis genes ( Figure 1B ). Both complemented the Q − phenotype and thus were active as PTPS-I enzymes (Table 1) . Only PTPS-I/III Cb complemented the dT auxotrophy phenotype, and thus exhibited PTPS-III activity ( Figure 2C ). These results show that COG0720 members that contain hybrid PTPS-III/I motifs are active in both folate and Q biosynthesis pathways and that the conserved cysteine in that motif is critical for PTPS-I activity but not PTPS-III activity.
Role of COG0720 Family Proteins in Archaea
All Euryarchaeaota predicted to synthesize preQ 0 because of the presence of the queCE genes encode a PTPS-I like protein (See "Experimental PTPS" subsystem in SEED). PTPS-I genes are surprisingly absent in many Crenarchaea, some of which are known to make G + (36), although many have the PTPS-V or PTPS-VI variant. Finally, several archaeal genomes encode more than one COG0720 protein (Experimental data 1), such as Haloferax volcanii, which contains both putative PTPS-I (HVO_1718) and PTPS-IV genes (HVO_1282).
Because H. volcanii is known to contain G + -modified tRNA (37) and many of the genes encoding the biosynthetic enzymes have been identified (folE2, HVO_2348; queC, HVO_1717 and queE, HVO_1716) and shown to be essential for G + formation (20, 38), it was logical to propose that HVO_1718 encodes the QueD/PTPS-I protein involved in G + synthesis. A HVO_1718 derivative was constructed as described in the methods section. Subsequent analysis of ribonucleosides from bulk tRNA extracted from the H. volcanii WT and HVO_1718 strains grown in minimal medium showed that the peak observed for the molecular ion of G + (325 m/z), corresponding to the 26.2 min peak detected on the UV trace present in the WT H. volcanii H26 strain, was absent in the mutant strain ( Figure 3A) . Expression of the PTPS-I gene from Halobacterium sp. NRC1 (Vng6306) on the shuttle vector pJAM202 complemented the G + deficiency phenotype of the HVO_1718 strain (Supplemental Figure 2 ) clearly establishing HVO_1718 as encoding a functional PTPS-I.
The function of the PTPS-IV protein in H. volcanii is less clear. H. volcanii is rare among
Archaea in having a complete folate pathway (39, 40), but genes encoding FolB or PTPS-III could not be identified in this organism (41). One possibility is that while PTPS-IV lacks the PTPS-III signature motif, it functionally replaces FolB. To test this hypothesis a HVO_1282 strain was constructed, but unlike the H. volcanii folE2 mutant previously constructed (42) it did not require dT for growth, suggesting that PTPS-IV is not involved in folate biosynthesis ( Figure 3B ). Physical clustering suggested a possible link between PTPS-IV and riboflavin biosynthesis ( Figure 1B) . Some of the canonical riboflavin biosynthetic genes are known to be missing in Archaea (35), thus we tested the involvement of HVO_1282 in riboflavin biosynthesis. As a control, we constructed a H. volcanii ribA deletion strain ( HVO_1284); as shown on Figure 3C , no growth defect in the absence of riboflavin was observed in the HVO_1282 strain, whereas the HVO_1284 strain required riboflavin to grow as expected. At this point however, even if comparative genomic analysis links the PTPS-IV family to the synthesis of an APy derivative, the family does not appear to be directly involved in the synthesis of riboflavin.
Finally, we investigated whether the variant COG0720 members found in Sulfolobus solfataricus or in Pyrobaculum calidifontis had QueD or FolB activity in E. coli complementation tests. We found that the SSO2412 gene (PTPS-VI family) could complement the dT auxotrophy of the folB mutant ( Figure 3D ) but not the Q deficiency of the queD strain (Table 1) . We failed to see any complementation of either phenotype by the Pcal_1063 gene (PTPS-V family) in the conditions tested.
In Vitro and In Vivo Flexibility of the Bacterial and Archaeal PTPS-I Catalytic Site
An exhaustive comparative analysis of the Zur regulon (43) revealed that certain bacteria contained two copies of the queD/PTPS-I gene, queD and queD2, with queD2 predicted to be under the control of negative regulator Zur (Supplemental Table 2 ). Zur is a repressor that responds to zinc levels and upregulates genes under its control when zinc is low (44). These include genes encoding high-affinity zinc transporters such as ZnuABC, and paralogs of zinc dependent enzymes that can use metals other than zinc (45). Analysis of the QueD2 sequences showed that these harbored a {C-X(4)-H-G-H} motif instead of the {C-X(3)-H-G-H} found in canonical QueD/PTPS-I enzymes (Supplemental Table 2 ). Furthermore, certain organisms, such as Acinetobacter baylyi sp. ADP1, contain only a queD2 gene and no queD gene (Supplemental Table 2 ). To test whether QueD2 proteins were functional PTPS-I enzymes we expressed the A. baylyi sp. ADP1 queD2 Ab gene (YP_046954.1) in the E. coli queD strain (VDC4660). As shown in Table 1 , complementation of the Q − phenotype was observed, confirming QueD2 does possess PTPS-I activity. Interestingly, introducing the Lys23Cys and Cys24Ser mutations in the E. coli QueD protein, thereby changing the {KC-X(3)-H-G-H} motif to a {C-X(4)-H-G-H} motif, also allowed functional complementation ( Table 1 ), suggesting that the PTPS-I catalytic pocket is quite plastic. To probe this idea further, we tested if PTPS-II enzymes, with {C-X(5)-H-G-H} signature motifs, also exhibited PTPS-I activity. Previous studies had shown that PTPS-I from Synechococcus sp. PCC7942 did possess PTPS-II activity in vitro (albeit only 10% of the activity of the canonical PTPS-II from the same organism) (27), but the reverse scenario had never been tested. As shown in Figure 2B and Table 1 , expressing the rat ptpS Rn gene in the E. coli queD mutant (strain VDC3331) did restore the production of Q, demonstrating that the rat PTPS-II exhibited enough PTPS-I activity to functionally replace the chromosomal encoded queD, at least when expressed on a multicopy plasmid. Finally, we tested whether a motif containing a shortened spacer {C-X(2)-H-G-H} still led to a functional PTPS-I enzyme by transforming the E. coli queD and folB strains with a plasmid expressing a mutant PTPS-I/III Sa enzyme possessing the Cys26Ala and Glu27Cys double mutation. Like the Cys26Ala single mutant, this clone failed to complement the Q − phenotype, but unlike the single mutant, it also failed to complement the dT auxotrophy ( Table 1 ).
The plasticity of the PTPS active-site had already been suggested by the report that the E. coli PTPS-I/QueD enzyme displayed relaxed substrate selectivity in vitro, utilizing H 2 NTP or sepiapterin to form 6-pyruvoyl-tetrahydropterin (PTPS-II activity) or 7,8-dihydropterin, respectively, the latter a fundamentally new activity of side-chain cleavage (21, 46). Using a direct in vitro assay for activity that eliminates potential artifacts introduced through postreaction work-up, the activity of the E. coli enzyme was subsequently shown to produce only 6-carboxy-5,6,7,8-tetrahydropterin (CPH 4 ) (21), the biologically relevant product. We show here that this enzyme is able to produce CPH 4 from several substrates, including H 2 NTP, sepiapterin, and dihydroneopterin monophosphate (H 2 NMP) ( Figure 4A-E) .
Collectively these results demonstrate that the E. coli QueD enzyme is able to catalyze the formation of a common product from multiple substrates.
To test if other members of the PTPS-I family shared this substrate plasticity, we investigated the catalytic activity of the predicted archaeal PTPS-I enzyme from Methanocaldococcus jannaschii, MJ1272. We first confirmed that MJ1272 was a member of this family as it catalyzed the formation of CPH 4 from the expected biological substrate, dihydroneopterin-2',3'-cyclic phosphate (H 2 NMPc) (47) ( Figure 4F ). The generation of CPH4 in these reactions was established by detection of two of its oxidative decomposition products, 6-carboxypterin and pterin. The pterin was labeled with deuterium when the incubation was conducted in deuterated water, consistent with the incorporation of deuterium at C-6 during retroaldol reaction leading to the formation of CPH4. This was retained and measured in the pterin produced by its subsequent oxidative decomposition. Furthermore, MJ1272 also exhibited good activity with a variety of other pterin substrates, including dihydroneopterin, sepiapterin and H 2 NMP (as shown on Figure 4F ). These results demonstrate that, like the E.coli QueD, MJ1272 can catalyze the formation of a common product from multiple substrate pterins.
Structural Analysis of the COG0720 Family
The PTPS-II family has been the most thoroughly investigated structurally, and a detailed chemical mechanism has been proposed (48). The 3D structure of the rat liver PTPS-II exhibits a homohexameric structure formed by a dimer of trimers with 3-fold symmetry (5). Based on molecular modeling, site-directed mutagenesis, and refined crystal structures of the enzyme alone and in complex with natural substrate, it was shown that substrate binding occurs at the interface of 3 subunits, comprising two subunits from one trimer and one subunit from the opposing trimer (48). Because of this structure, catalytically important residues are contributed from multiple subunits. For example, the active site residue Cys42 (Rattus norvegicus PTPS-II numbering) is contributed from a subunit of one trimer, while Asp88 and His89, which complete the catalytic triad with Cys42, and the Zn 2+ binding residues His23, His48, and His50 are contributed by a subunit in the adjacent trimer (48, 49). The proposed reaction involves base-catalyzed isomerization followed by triphosphate elimination (48, 50), with Zn 2+ serving to activate the substrate and stabilize the intermediates so as to disfavor breaking of the C1-C2 bond in the pyruvoyl side-chain (48).
To gain insight into the structural basis for plasticity of the PTPS active sites, the structure of rat PTPS-II that produces 6-pyruvoyltetrahydropterin (PDB: 1B66) was compared with the structure of the Pseudomonas aeruginosa PTPS-I that produces CPH 4 (PDB: 2OBA) using the Accelrys Discovery Studio 2.5 tool. Structural superimposition was made based on monomers of each protein structure. The best global fit was obtained when using the PTPS-II structure from R. norvegicus as a reference with the following three homology regions as anchoring sites: the region from Thr66 to Gly67, the region from Thr105 to Glu107, and the third from Glu133 to Tyr134 (R. norvegicus numbering) ( Figure 5A ). Overall, the two structures superimpose with a rmsd of 0.4. The spatial locations of the canonical T-fold Glu residues, which interact with the exocyclic 2-amino group of the pterin, are conserved in both structures (Glu 133/Glu107) (48). The catalytic residues Asp88 and His89 (R. norvegicus numbering) of the active site are superimposable with the catalytic residues Asp67 and His68 of the P. aeruginosa PTPS-I (PDB: 2OBA). The Zn 2+ binding His residues of PTPS-II (His23, His48 and His50) (48) occupy the same coordinates as the Zn 2+ binding residues (His13, His28 and His30) of PTPS-I ( Figure 5B ). Although the catalytic Cys residues involved in catalysis do not completely overlap, the distances from Cys to Zn 2+ are similar in both enzymes (Figure 5 Table inset ). Despite these shared active site characteristics, the R. norvegicus PTPS-II has two extra helix domains around the active-site region, one found on the N-terminal side adjacent to Cys42 and the other around Asp88/ His89 ( Figure 5A ).
The superimposition of the PTPS-I from P. aeruginosa (PDB: 2OBA chainA) and PTPS-III from Plasmodium falciparum (PDB: 1Y13 chain A) performed with the rigid FATCAT algorithm showed that the two structures superimpose with a rmsd of 2.21 ( Figure 5C ). As was observed in the comparison of the PTPS-I and PTPS-II structures, most of the conserved catalytic residues overlap well; thus, Asp67 and His68 (in PTPS-I overlap with the Asp79 and His80 in PTPS-III, the spatial coordinates of the three Zn 2+ binding His residues are conserved in both structures, and the spatial locations of the canonical T-fold Glu residues are conserved in both structures (Glu107/Glu161) ( Figure 5C and D) . Furthermore, while the key catalytic residue Cys24 in PTPS-I is replaced by Glu38 in the active site of PTPS-III ( Figure 5D ), the distances of the side chain groups of Cys24 and Glu38 to the respective Zn 2+ are similar, thus the spatial positions of the two putative general acid/base residues with respect to Zn 2+ are comparable in the two enzymes (Figure 5  Table inset ). However, there are noteworthy differences between the two structures; the loops containing the active site do not overlap completely, and PTPS-III has an extra loop close to the active site region ( Figure 5C ). Despite the active sites similarities among the three PTPS enzymes, the notable differences around the active sites could influence substrate binding allowing the production of different products.
DISCUSSION
The combination of comparative genomic analyses and experimental validation allowed separation of the COG0720 family into at least six functional subfamilies (PTPS-I through PTPS-VI), illustrating the diversity of its catalytic potential. The subfamilies have similar but distinct catalytic activities and are involved in different pathways, three of which have been identified: folate biosynthesis for PTPS-III, Q/G + biosynthesis for PTPS-I, and biopterin biosynthesis for PTPS-II. Of particular interest is the observation that some members of the COG0720 family have both PTPS-I and PTPS-III activity in vivo, and that these proteins harbor a hybrid catalytic motif {C-E-X(2)-H-G-H}. This is an example where catalytic promiscuity of a single enzyme satisfies different metabolic needs in different pathways. An example of this phenomenon is observed with o-succinylbenzoate synthase (OSBS), a member of the enolase superfamily, which functions both as succinylbenzoate synthase in menaquinone biosynthetic pathway and as an N-succinylamino acid racemase (NSAR) in racemization of N-acetylmethionine (51, 52). Only an amino acid change (changing {C-X(3)-H-G-H} to {C-E-X(2)-H-G-H}) is necessary to transform a PTPS-I into a PTPS-I/III (15) and only one additional mutation (the Cys to another amino acid) is required to transform a PTPS-I/III to a PTPS-III. This latter phenomenon, in which the identity of a single residue can change the predominant product of the enzyme, is similar to observations of the GCYH II/III enzymes, where a single Tyr or Met residue at a key position results in an enzyme with type-II or type-III activity, respectively (34).
While PTPS-I is able to accept a variety of substrates in vitro, the actual biological substrate for PTPS-I enzymes remains uncertain. In Archaea the product of GCYH-I is H 2 NMPc (47), while in Bacteria it is H 2 NTP, so it is possible that both are further processed by a phosphatase to form H 2 NMP as the relevant substrate in vivo. Further work is needed to differentiate between these two possibilities.
The functions the COG0720 family members might also be dependent on the identity of the bound metal. PTPS-II enzymes are thought to be zinc dependent (49), and while the metal dependence of PTPS-III enzymes have not been rigorously determined, the structures of the P. falciparum (PDB: 1Y13) and Plasmodium vivax (PDB: 2A0S) proteins show a bound Zn 2+ . Interestingly, in the PTPS-I family the archaeal member MJ1272 appears to be Fe 2+ dependent (see Supplemental material). This might be a methanogen specific trait as M. jannaschii FolE2 (or MptA), another T-fold superfamily member, is also Fe 2+ dependent (47) whereas in bacteria such as B. subtilis and Neisseria gonorrhoeae the enzyme is most active with Mn 2+ (11). Finally, genes encoding QueD2 variants with a different active-site signature [{C-X(4)-H-G-H} instead of {C-X(3)-H-G-H}] were predicted to be under Zur regulation, consistent with the canonical QueD requiring zinc whereas the QueD2 enzymes use another metal. Several cases are now known in which paralogs of zinc dependent enzymes that use metals other than zinc are upregulated when zinc is low (see (53) for examples). Nevertheless, while the existing data is compelling, detailed investigation of the metal dependence of these enzymes will be required to determine if varied metal dependence in fact contributes to the catalytic potential of COG0720 members.
Consideration of the transformations catalyzed by PTPS-I, PTPS-II, and PTPS-III reveal that each can be explained by the involvement of general acid/base catalysis in mediating isomerization, elimination, retroaldol, cleavage/elimination, and hydration reactions ( Figure 6 ). Thus PTPS-III requires only a retroaldol cleavage and isomerization to produce dihydro-6-hydroxymethylpterin, PTPS-II requires an isomerization followed by an elimination of triphosphate to produce 6-pyruvoyltetrahydropterin. The fact that PTPS-I can utilize sepiapterin as well as H 2 NTP (and the di-and monophosphates) led to the proposal (21) of a mechanistically complex series of reactions in which the first three reactions are the same as that used by PTPS-II to produce PTP, followed by two isomerization reactions, a hydration and finally a retroaldol reaction to produce CPH 4 . However, given the observed promiscuity of these enzymes it is possible that the activity with sepiapterin does not reflect an actual role in the reaction catalyzed with H 2 NTP, as one can envision a much simpler route to CPH 4 in two steps via similar acid/base catalyzed transformations ( Figure 6 ); differentiating these 2 pathways may be possible by evaluating the kinetic competence of sepiapterin once PTPS-I has been kinetically characterized with the dihydroneopterin substrates. Overall, the products of the various PTPS enzymes are all accessible via subtle changes in the expression of general acid/base catalysis operating in each of these systems.
Even after this extensive characterization of the COG0720 family many questions remain. The function of the PTPS-IV subfamily is still unknown: it was already known not to function as a PTPS-II (25). We have shown here that it possesses neither PTPS-III nor PTPS-I activity, and that it has no direct role in riboflavin synthesis. PTPS-I is missing in many Crenarchaea that make G + , such as Sulfolobus or Pyrobaculum species (19, 36, 54) (see "Experimental-PTPS" subsystem in SEED), and possible candidates for this activity are the PTPS-V and PTPS-VI families that are found in many Crenarchaea (Supplemental data 1). However, while expressing the PTPS-VI from S. solfataricus SSO2412 complemented an E. coli folB mutant, it did not complement a queD mutant, so it is unlikely that the PTPS-VI family harbors the missing PTPS-I activity in Crenarchaea. Notably, while the PTPS-VI enzymes exhibit PTPS-III activity (based on the folB complementation result), they lack the PTPS-III signature motif. Further biochemical work will be required to fully characterize this complex COG0720 family.
METHODS
Chemicals
All chemicals were obtained from Aldrich/Sigma unless otherwise indicated.
Bioinformatics
Analysis of the phylogenetic distribution and physical clustering was performed in the SEED database (29). Results are available in the "Experimental-PTPS" subsystem on the public SEED server (http://theseed.uchicago.edu/FIG/subsys.cgi). We also used the BLAST tools and resources at NCBI (28). The H. volcanii genome sequence was accessed through the UCSC archaeal genome browser (55). Multiple alignments were built using the ClustalW tool (56). The PRATT tool (31) from Prosite website (http://expasy.org/prosite/) was used to derive the specific protein motifs. These motifs were used to examine the COG0720 family using ScanProsite (57). The same Prosite motifs were also used to search for pattern occurrence in protein queries using Phi-BLAST at NCBI (58). Web logo (http://weblogo.berkeley.edu/logo.cgi) (32) was used to create sequence logos for the four PTPS families. Structure based alignments were performed using the Espript platform (http://espript.ibcp.fr/ESPript/ESPript/) (59).
Three Dimensional (3D) Structure Superimposition
First, the sequences of PTPS-I from P. aeruginosa (PDB: 2OBA) and PTPS-II from R. norvegicus (PDB: 1B6Z) were aligned using ClustalW2 (56) to find conserved regions along the aligned sequences that were used as anchoring points for the superimposition. The 3D superimpositions were performed using the superimposition tool of the software "Discovery Studio 2.5" (http://accelrys.com/) (60, 61) and the superimposition tools of Protein Data Bank (PDB) (http://www.pdb.org).
Strains, Media, Growth, and Transformation
All strains and plasmids used are listed in Supplemental Table 3 . E. coli derivatives were routinely grown at 37°C in LB (BD Diagnostic System) or minimal M9 medium (62) supplemented with 0.4% glycerol as a carbon source. Growth media were solidified with 15 g l −1 agar (BD Diagnostic System) for the preparation of plates. Transformations of E. coli were performed following standard procedures (62) Ampicillin (Amp, 100 µg ml −1 ), Thymidine (dT, 300 µM), Kanamycin (Kan, 50 µg/ml), isopropyl-beta-Dthiogalactopyranoside (IPTG, 1 mM) and L-arabinose (0.2%) were added when needed. H. volcanii derivatives were grown at 45 °C in Hv-YPC rich medium (63) and Hv-min minimal medium (64). Riboflavin (20 µg ml −1 ), uracil (50 or 10 µg ml −1 ), novobiocin (Nov, 0.2 µg ml −1 ) and 5-fluoroorotic acid (FOA, 50 µg ml −1 ) were added when needed. H. volcanii growth media was solidified with 20 g 1 −1 agar (BD Diagnostic System) for preparation of the plates. Transformations of H. volcanii were performed essentially as described (65).
Plasmid and Strain Constructions for Genetic Studies
All primers used for plasmid and strain construction, site directed mutagenesis and strain verification are listed in Supplemental Site directed mutagenesis was performed as described previously (66) using the specific oligonucleotides pairs listed in Supplemental Table 4 . The resulting plasmids were verified by Sanger sequencing at the U of F core facility.
The ygcM::Kan r deletion was transferred by P1 transduction (70) from the E. coli JW2735-2 strain from the Keio collection (71) into E. coli K12 MG1655. The Kan r marker was then excised using the Flp recombinase (72) to create the ygcM strain (VDC2043).
The folB::Kan r deletion was transferred by P1 transduction (70) from the E. coli JW3030-2 strain from the Keio collection (71) into E. coli K12 MG1655 yielding strain VDC3276. Deletion of both folB and ygcM and excision of the Kan r gene were confirmed by PCR. The H. volcanii HVO_1718 deletion strain was constructed as described previously (42). The H. volcanii HVO_1282 and HVO_1284 strains were constructed as previously described (38). Deletions of the genes were checked by PCR as shown in Supplemental Figure 3 .
Cloning and Expression of the M. jannaschii MJ1272 Gene
The M. jannaschii gene MJ1272 (NP_248268.1) was amplified by PCR from genomic DNA by using oligonucleotide primers. The primers used were MJ1272-Fwd and MJ1272-Rev. PCR amplification was performed using a 55°C as annealing temperature. The PCR product was purified by using a QIAquick spin column and digested with NdeI and BamHI restriction enzymes and then ligated into compatible sites in plasmid pT7-7 to make the recombinant plasmid pMJ1272. DNA sequence was verified by dye-terminator sequencing at the DNA Facility of Iowa University. The resulting plasmid was transformed into E.coli strain BL21-Codon Plus (DE3)-RIL. The transformed cells were grown in Luria-Bertani medium supplemented with 100 µg mL −1 Amp at 37°C with shaking until they reached an OD 600 of 1.0. Recombinant protein production was induced by addition of lactose to a final concentration of 28 mM. After an additional 2 hours of culture, the cells were harvested by centrifugation (4,000 ×g, 5 min) and frozen at −20°C. E. coli cells expressing recombinant protein were resuspended in 4 mL extraction buffer (50 mM Ntris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES) pH 7.0, 10 mM MgCl 2 , 20 mM DTT) and lysed by sonication. After precipitating the majority of E. coli proteins by heating the cell lysate to 80°C for 10 min, the MJ1272-derived protein was purified by anion exchange chromatography on a MonoQ HR column (1 × 8 cm, Amersham Bioscience) with a linear gradient from 0-1 M NaCl in 25 mM TES pH 7.5 over 55 mL at 1 ml min −1 . The purified protein ran as a single band at approximately 18 kDa, consistent with the predicted molecular weight of 18.8 kDa, and was >98% pure as judged by SDS-polyacrylamide gel electrophoresis with coomassie blue staining. Protein concentration was determined by Bradford analysis (73).
Enzyme Assay of M. jannaschii MJ1272
The standard assay for MJ1272 consisted of 5-15 µg MJ1272, 25 mM TES/K + buffer pH 7.0, 5 mM MgCl 2 , 10 mM DTT, and ~1.0 mM substrate (sepiapterin, H 2 neopterin, H 2 neopterin-P) in a total volume of 50 µL. When required, 2 mM Fe +2 was also included in the incubation mixture. For assays utilizing H 2 neopterin 2',3'-cyclic phosphate, 1.9 µg MptA, 2 mM MnCl 2 and 2 mM GTP were also included in the incubation mixture (47). The product of the MptA reaction was confirmed by the absorbance using a diode array detector. 6-Carboxypterin was also confirmed by the formation of the methyl ester with HCl/ Methanol and reanalysis by HPLC. To test the involvement of cysteine in the reaction MJ1272 (~10 µg) was preincubated in reaction buffer with 2 mM iodoacetamide for 1 hr at room temperature and then assayed for activity with sepiapterin as the substrate according to the standard assay procedures.
Assays were typically incubated for 30 min at 70°C and quenched by the addition of 60 µL methanol. Reaction products were oxidized to the fluorescent pterins by addition of 5 µL iodine in MeOH (50 mg/mL) and the samples were incubated at room temperature for 30 min. Excess iodine was reduced by addition of 5 µL 1 M NaHSO 3 . Following centrifugation (14,000 × g, 10 min), 4 µL portion was separated for TLC analysis and the remainder combined with 600 µL H 2 O for HPLC analysis. For samples incubated with D 2 O, 50% of the water in the incubation mixture was replaced with D 2 O.
Chromatographic separation and analysis of pterins was performed on a Shimadzu HPLC (High performance liquid chromatography) System with a C18 reverse phase column (Varian PursuitXRs 250 × 4.6 mm, 5 µm partical size). The elution profile consisted of 5 min at 95% sodium acetate buffer (25 mM, pH 6.0, 0.02% NaN 3 ) and 5% MeOH followed by a linear gradient to 20% sodium acetate buffer/80% MeOH over 40 min at 0.5 mL/min. Pterins were detected by fluorescence using an excitation wavelength of 356 nm and an emission wavelength of 450 nm. Under these conditions, the pterins were eluted in the following order (min): D-neopterin 2',3'-cyclic phosphate (7.6), 6-carboxypterin (8.4), neopterin (11.0), pterin (16.8), 6-hydroxymethylpterin (16.8) and 6,7-dimethylpterin (27.0). The pterins were also identified by TLC (Thin layer chromatographies) with fluorescence detection. The following R f were observed using acetonitrile-water-formic acid (88%), 40:10:5 v/v/v as the developing solvent: pterin-6-carboxylate methyl ester, 0.63; pterin, 0.465; 6-hydroxymethylpterin, 0.45; biopterin, 0.44; neopterin, 0.31; and pterin-6-carboxylate, 0.24.
In order to separate 6-hydroxymethylpterin from pterin a polyfluorophenyl column (Varian Pursuit-PFP column 250 × 4.6 mm 5 µ) was used with the HPLC system. The elution profile was isocratic 25 mM sodium acetate buffer pH 6.0 over 45 min at 0.5 ml min −1 . With these conditions pterin eluted at 27 min and 6-hydroxymethylpterin at 29 min.
For GC-MS analysis, pterins were purified from incubation mixtures by retention on a Dowex 50W-8X-H + column followed by elution with 7 M aqueous ammonia. Pterins was analyzed for deuterium incorporation either by direct insertion (DI) mass spectral of the pterin, M + = 163 m/z or by DI or GC-MS analysis of the pterin (TMS) 2 derivative with M + = 307 m/z and M + −15 = 292 m/z. For the GC-MS analysis of the pterins, the individual pterins were purified by preparative TLC from the ammonia eluted material and analyzed as their TMS derivatives as previously described (74).
Enzyme Assays of E. coli QueD
The ygcM gene from E. coli, which encodes QueD (PTPS-I), was amplified from E. coli genomic DNA using primers ECygcmS and ECygcmAS, and cloned using ligationindependent cloning into the plasmid pET30-Xa (Novagen) following the manufacturer's instructions. The integrity of the sequence was confirmed by sequencing (PSU-Keck Genomics Facility, Portland State University). Recombinant QueD was over-produced in E. coli BL21(DE3) using standard protocols, and purified as an N-terminal His 6 -affinity tagged fusion protein via Ni-NTA affinity chromatography, then cleaved via Factor Xa to give the native wild-type enzyme.
Assays of recombinant E. coli QueD activity were carried out in reactions containing 100 mM Tris-HCl (pH 8.0), 100 mM KCl, 2 mM MgCl 2 , 2 mM DTT, 0.5 mM 7,8-dihydroneopterin monophosphate (H 2 NMP) and 50 µM QueD, and were monitored by LC-ESI-MS at 360 nm. Coupled reactions involving GCYH-IB (50 µM) from N. gonorrhoeae, 50 µM QueD, and 0.5 mM GTP were also carried out. Reactions were incubated at 37°C for 60 min in the dark under anaerobic conditions. The protein was removed from the solution using a YM-10 micron centrifugal device, and the eluent subjected to LC-ESI-MS analysis on a Bruker MicroTOF-Q equipped with a Supelco Discovery C18 column (25 cm × 2.1 mm, 5 um particles) eluted at 0.3 mLmin −1 with an solvent gradient of 5% solvent A (0.1% formic acid in water) for 5 min, then 5-50% of solvent B (0.1% formic acid in acetonitrile) in 25 min.
tRNA Extraction and Analysis Bulk tRNA was prepared, hydrolyzed, and analyzed by liquid chromatography tandem mass spectrometry (LC-MS-MS) as described in (75) from cells grown in chemically defined medium. To evaluate tRNA concentrations, we measured the levels of the m 1 G-modified base (298 m/z at 21 min.) by integrating the peak area from the extraction ion chromatograms and compared them between samples. The MS-MS fragmentation data were also used to confirm the presence or absence of the nucleosides, Q and G + . All tRNA extractions and analysis were performed at least twice independently.
